Clinical Randomised Phase 2 Trial of AP31969 Versus Placebo for Rhythm Control of Atrial Fibrillation
NCT07267949 · Status: RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 200
Last updated 2025-12-05
Summary
A clinical Randomized Phase 2 Trial of AP31969 versus Placebo for Rhythm Control of Atrial Fibrillation.
Conditions
- Atrial Fibrillation (AF)
Interventions
- DRUG
-
AP31969
Tablets, Oral, Twice daily.
- DRUG
-
Tablets, oral, Twice daily.
Sponsors & Collaborators
-
Acesion Pharma
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-10-22
- Primary Completion
- 2026-11-30
- Completion
- 2026-12-31
Countries
- Bulgaria
- Denmark
- Germany
- Hungary
- Italy
- Netherlands
- Poland
Study Locations
More Related Trials
-
Study to Determine the Response and Effectiveness of RSD1235 in Subjects With Atrial Fibrillation or Atrial Flutter
NCT00115791 ·Status: COMPLETED ·Phase: PHASE3
-
Prevention Of Recurrence Of Atrial Fibrillation
NCT00041496 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Ablation Versus antiaRrhythmic Drugs in Persistent Atrial Fibrillation
NCT00863213 ·Status: COMPLETED ·Phase: PHASE4
-
Study of RSD1235-SR for the Prevention of Atrial Fibrillation/Atrial Flutter Recurrence
NCT00267930 ·Status: COMPLETED ·Phase: PHASE2
-
Cardiac Electrophysiological Study
NCT00616629 ·Status: COMPLETED ·Phase: PHASE2
-
Atrioventricular Junction Ablation and Biventricular Pacing for Atrial Fibrillation and Heart Failure
NCT02137187 ·Status: UNKNOWN ·Phase: PHASE3
-
A Study to Investigate the Efficacy, Safety, Tolerability and Pharmacokinetics of PKN605 in Participants With Atrial Fibrillation
NCT07217067 ·Status: RECRUITING ·Phase: PHASE2
-
Response to RSD1235 Compared to Placebo in Subjects With Atrial Arrhythmia After Heart Surgery
NCT00125320 ·Status: COMPLETED ·Phase: PHASE3
-
To Evaluate the Impact of Oral Flecainide on Quality of Life in Patients With Paroxysmal Atrial Fibrillation
NCT00189319 ·Status: COMPLETED ·Phase: PHASE4
-
Paroxysmal Atrial Fibrillation: Role of Inflammation, Oxidative Stress Injury and Effect of Statins
NCT00321802 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Azimilide in the Prophylactic Treatment of Patients With Atrial Fibrillation.
NCT00035464 ·Status: COMPLETED ·Phase: PHASE3
-
Investigation of the Adagio Cryoablation System in Patients With Atrial Fibrillation
NCT02839304 ·Status: COMPLETED ·Phase: NA
-
A Study of the Effectiveness of Anti-Arrhythmic Medications After Atrial Fibrillation Ablation
NCT00408200 ·Status: COMPLETED ·Phase: NA
-
Antiarrhythmic Drugs Assessment in Preventing Atrial Fibrillation
NCT02145546 ·Status: UNKNOWN ·Phase: PHASE4
-
Atrial Fibrillation Ablation and Autonomic Modulation Via Thorascopic Surgery
NCT01091389 ·Status: COMPLETED ·Phase: PHASE4
-
Ranolazine in Atrial Fibrillation Following An ELectricaL CardiOversion
NCT01534962 ·Status: COMPLETED ·Phase: PHASE2
-
Pulsed-field Ablation Vs. Sham Ablation to Treat AF
NCT05717725 ·Status: RECRUITING ·Phase: PHASE3
-
Withdrawal Versus Continuation of Amiodarone in Successfully Treated Patients With Persistent Atrial Fibrillation
NCT00845780 ·Status: COMPLETED ·Phase: PHASE4
-
Atrial Fibrillation: Ablation or Surgical Treatment II: FAST II
NCT01336075 ·Status: TERMINATED ·Phase: NA
-
Catheter Ablation of All Inducible AT Post AF Ablation
NCT03343860 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of HSY244 in Participants With Atrial Fibrillation
NCT04582409 ·Status: TERMINATED ·Phase: PHASE2
-
Electrophysiological Effects of Irbesartan in Patients With Paroxysmal Atrial Fibrillation (AF)
NCT00352560 ·Status: COMPLETED ·Phase: PHASE3
-
Prophylaxis for Patients at Risk to Eliminate Post-operative Atrial Fibrillation
NCT04392921 ·Status: UNKNOWN ·Phase: NA
-
Efficacy and Safety of Azimilide for the Treatment of Patients With Atrial Fibrillation
NCT00035477 ·Status: COMPLETED ·Phase: PHASE3
-
Comparative Study of Flecainide CR and Placebo in the Early Treatment of Atrial Fibrillation.
NCT00408473 ·Status: TERMINATED ·Phase: PHASE4